TY - JOUR
T1 - Persistent changes in liver methylation and microbiome composition following reversal of diet-induced non-alcoholic-fatty liver disease
AU - Kim, Hyejin
AU - Worsley, Oliver
AU - Yang, Edwin
AU - Purbojati, Rikky Wenang
AU - Liang, Ai Leng
AU - Tan, Wilson
AU - Moses, Daniela I.Drautz
AU - Hartono, Septian
AU - Fan, Vanessa
AU - Lim, Tony Kiat Hon
AU - Schuster, Stephan C.
AU - Foo, Roger Sy
AU - Chow, Pierce Kah Hoe
AU - Pettersson, Sven
N1 - Publisher Copyright:
© 2019, Springer Nature Switzerland AG.
PY - 2019/11/1
Y1 - 2019/11/1
N2 - Non-alcoholic fatty liver disease (NAFLD) is a metabolic liver disease that is thought to be reversible by changing the diet. To examine the impact of dietary changes on progression and cure of NAFLD, we fed mice a high-fat diet (HFD) or high-fructose diet (HFrD) for 9 weeks, followed by an additional 9 weeks, where mice were given normal chow diet. As predicted, the diet-induced NAFLD elicited changes in glucose tolerance, serum cholesterol, and triglyceride levels in both diet groups. Moreover, the diet-induced NAFLD phenotype was reversed, as measured by the recovery of glucose intolerance and high cholesterol levels when mice were given normal chow diet. However, surprisingly, the elevated serum triglyceride levels persisted. Metagenomic analysis revealed dietary-induced changes of microbiome composition, some of which remained altered even after reversing the diet to normal chow, as illustrated by species of the Odoribacter genus. Genome-wide DNA methylation analysis revealed a “priming effect” through changes in DNA methylation in key liver genes. For example, the lipid-regulating gene Apoa4 remained hypomethylated in both groups even after introduction to normal chow diet. Our results support that dietary change, in part, reverses the NAFLD phenotype. However, some diet-induced effects remain, such as changes in microbiome composition, elevated serum triglyceride levels, and hypomethylation of key liver genes. While the results are correlative in nature, it is tempting to speculate that the dietary-induced changes in microbiome composition may in part contribute to the persistent epigenetic modifications in the liver.
AB - Non-alcoholic fatty liver disease (NAFLD) is a metabolic liver disease that is thought to be reversible by changing the diet. To examine the impact of dietary changes on progression and cure of NAFLD, we fed mice a high-fat diet (HFD) or high-fructose diet (HFrD) for 9 weeks, followed by an additional 9 weeks, where mice were given normal chow diet. As predicted, the diet-induced NAFLD elicited changes in glucose tolerance, serum cholesterol, and triglyceride levels in both diet groups. Moreover, the diet-induced NAFLD phenotype was reversed, as measured by the recovery of glucose intolerance and high cholesterol levels when mice were given normal chow diet. However, surprisingly, the elevated serum triglyceride levels persisted. Metagenomic analysis revealed dietary-induced changes of microbiome composition, some of which remained altered even after reversing the diet to normal chow, as illustrated by species of the Odoribacter genus. Genome-wide DNA methylation analysis revealed a “priming effect” through changes in DNA methylation in key liver genes. For example, the lipid-regulating gene Apoa4 remained hypomethylated in both groups even after introduction to normal chow diet. Our results support that dietary change, in part, reverses the NAFLD phenotype. However, some diet-induced effects remain, such as changes in microbiome composition, elevated serum triglyceride levels, and hypomethylation of key liver genes. While the results are correlative in nature, it is tempting to speculate that the dietary-induced changes in microbiome composition may in part contribute to the persistent epigenetic modifications in the liver.
KW - DNA methylation
KW - Epigenetics
KW - Gut microbiome
KW - High-fat diet
KW - NAFLD
UR - http://www.scopus.com/inward/record.url?scp=85066139813&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066139813&partnerID=8YFLogxK
U2 - 10.1007/s00018-019-03114-4
DO - 10.1007/s00018-019-03114-4
M3 - Article
C2 - 31119300
AN - SCOPUS:85066139813
SN - 1420-682X
VL - 76
SP - 4341
EP - 4354
JO - Cellular and Molecular Life Sciences
JF - Cellular and Molecular Life Sciences
IS - 21
ER -